Spitzer’s Lawsuit Will Shake Up the Drug Industry – Full Disclosure is the Goal Thu, 3 Jun 2004 New York State Attorney General, Eliot Spitzer’s lawsuit against GlaxoSmithKline challenges the pharmaceutical industry’s fraudulent marketing of drugs. Karen Barth Menzes, an attorney representing victims of antidepressant drug effects, told The (So….
How Health Care in America Became Big Business–And Bad Medicine – OpEd NYT Zoloft NYT Ad Fails to Disclose Suicide risk Mon, 25 Oct 2004 An Op-Ed in Sunday’ New York Times by Time magazine editors, Donald Barlett and James Steele, is a MUST READ assessment of what ails America’s…
Medicare Rx Drug Bill Shaped by Drug Industry Blocks Elderly Bargaining Power – NYT Fri, 5 Sep 2003 A drug industry lobbyist is quoted in The New York Times stating: “Having both houses of Congress Republican-controlled was great. Like in Monopoly, when you get to add hotels.” The Medicare prescription…
Ethical Human Psychology and Psychiatry Volume 7, Number 2, Summer 2005 pp. 111-124 Screening for Mental Illness: The Merger of Eugenics and the Drug Industry Vera Hassner Sharav, MLS New York, NY The implementation by the President’s New Freedom Commission (NFC) to screen the entire United States population – children…
A Serious Drug Problem – The Medicare Prescription Bill of 2003 – Krugman Fri, 6 May 2005 New York Times columnist, Paul Krugman, hits the nail on the head when he points out who the beneficiaries of the Medicare law really are: Why it’s Big Pharma and those this industry…
Part II– Mental Health Screening: A Form of Child Abuse–Mother Jones http://www.motherjones.com/news/feature/2005/05/medicating_aliah.html enter subscriber code MJZL6Y Tue, 19 Apr 2005 This is a continuation of the earlier Infomail Re: Mental Health Screening expose by Rob Waters in Mother Jones – A detailed description of (what some would call) collusion by…
At FDA, Changes In Name Only–Agency Puts Business interests Above Safety Fri, 30 Sep 2005 The sudden resignation of FDA Commissioner, Lester Crawford, after just two months in office, has prompted a bipartisan Senate investigation and requests both by the Senate committee HELP and by congressman Maurice Hinchey (NY) and…
Whistleblowers: Dangerous Pursuit for Profits at the Expense of Patients’ Lives Sat, 12 Mar 2005 Several prescription drug sales reps have come out of the shadows. They’re blowing the whistle on the pharmaceutical industry’s corrupt practices’ sales reps view doctors’ offices as the trenches. Pfizer drug rep, Jamie Reidy, has…
Former FDA Commissioner says FDA lost public trust Mon, 17 Oct 2005 The FDA’s failure to ensure drugs are properly tested in trials designed to detect serious adverse effects, and the agency’s failure to require follow-up post-marketing studies to be reasonably secure in the knowledge that no lethal drugs are unleashed on the public has…
More Spent on Psych Drugs for preschool kids than antibiotics or asthma – AP Mon, 17 May 2004 Data analysis by MEDCO, the nation’s largest prescription benefit manager found that between 2000–2003 there was a 49% increase in the use of psychotropic drugs for children and a 369% increase in…
For the Sake of Public Safety FDA & NIH Must Be Detatched from Drug Industry Tue, 21 Dec 2004 Daily front page reports about lethal drug effects leave no doubt that we are in the midst of a major health safety and credibility crisis, largely due to a drug development…
FDA’s Lethal Weakness Requires More than Committees Sun, 7 Nov 2004 Bloomberg News reports that New York State Attorney General Eliot Spitzer requested information from Pfizer about the promotion of some of its drugs for unapproved uses – the recalled diabetes drug, Rezulin and the antidepressant, Zoloft were named. In…
